Steven Edward DeMartino;John Stephen Peanasky;Wendell P. Weeks;Robert Anthony Schaut
发明人:
Wendell P. Weeks,Robert Anthony Schaut,Steven Edward DeMartino,John Stephen Peanasky
申请号：
US13660704
公开号：
US20130202823A1
申请日:
2012.10.25
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, RITUXAN (rituximab), AVASTIN (Bevacizumab), LUCENTIS (Ranibizumab) or HERCEPTIN (trastuzumab).
